The short answer
Poly(ADP-ribose) polymerases respond to DNA damage by building ADP-ribose polymers, using NAD+ as the building block. Extensive or sustained damage can therefore consume a substantial fraction of the cellular pool.
Key facts
- Family
- Poly(ADP-ribose) polymerases (PARPs)
- Trigger
- DNA damage, particularly strand breaks
- Substrate
- NAD+, used as ADP-ribose donor
- Product
- Poly(ADP-ribose) chains
- Consequence
- Pool depletion under heavy damage
- Review
- Thapa 2021 (PMID 33387580)
What PARP does when DNA breaks
It binds the break and begins building branched chains of ADP-ribose on itself and on nearby proteins. Those chains are a recruitment signal: highly charged, immediately visible to repair machinery, and rapidly assembled. It is among the fastest responses a cell mounts to genomic damage.
Where the building material comes from
NAD+. Each ADP-ribose unit added to a chain is taken from an NAD+ molecule, releasing nicotinamide. That makes NAD+ a raw material here rather than a cofactor, and the chains can be long, so the consumption per damage event is not trivial.
Research material referenced
NAD+ 500mg, third-party HPLC tested
Why this can deplete the pool
Sustained or extensive DNA damage means sustained PARP activity, and sustained PARP activity means continuous NAD+ consumption. Under severe damage the draw can be large enough to compromise processes elsewhere that also need NAD+, including energy metabolism, so a repair response can create a metabolic problem.
The connection to the other consuming enzymes
Sirtuins consume NAD+ as a co-substrate. CD38 cleaves it extracellularly. PARPs use it as a polymer building block. Three families with unrelated functions all drawing on one pool means competition between them, and it is why NAD+ concentration is a shared resource rather than a private one.
Why PARP is a drug target
Thapa and colleagues reviewed PARP-1 as a target for neurodegenerative disease in Life Sciences in 2021, and PARP inhibitors are established in oncology on a separate rationale. An enzyme sitting at the junction of DNA repair and energy metabolism has several routes to therapeutic interest, which is why it appears in unrelated fields.
What this establishes about NAD+ levels
That they reflect demand as well as supply. A fall in NAD+ can mean less is being made or more is being consumed, and those have different causes and different implications. Measuring the level alone does not distinguish them, which is worth remembering when a decline is reported.
Frequently asked questions
What does PARP use NAD+ for?
As the building block for poly(ADP-ribose) chains, which recruit repair machinery to DNA damage.
Does a low NAD+ level mean less is being made?
Not necessarily. It can mean reduced synthesis or increased consumption, and the level alone does not distinguish them.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedThapa K et al., Poly(ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases. Life Sci 2021 (PMID 33387580)pubmed.ncbi.nlm.nih.gov
- PubMedCovarrubias AJ et al., Senescent cells promote tissue NAD+ decline via CD38. Nat Metab 2020 (PMID 33199924)pubmed.ncbi.nlm.nih.gov
- PubMedSauve AA: Curr Opin Chem Biol 2012 (PMID 23102634)pubmed.ncbi.nlm.nih.gov
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More NAD+ articles
- The Clock Controls NAD, and NAD Feeds Back on the ClockA 2009 Science paper showed the circadian clock controls the NAD+ salvage pathway, while the NAD-consuming enzyme SIRT1 regulates the clock.
- Separate Pools in Separate CompartmentsMitochondria, nucleus and cytosol maintain distinct nicotinamide dinucleotide pools. A 2021 Science paper showed one compartment's supply is essential.
- What Is NAD+? Structure, Role, and Why It Is Not a PeptideNAD+ is a dinucleotide coenzyme at 663.4 Da, not a peptide. What it does in metabolism, and why the research field works with precursors instead.
- Is NAD+ a Peptide? No, It Is a DinucleotideNo. NAD+ is a dinucleotide with no amino acids and no peptide bonds. Why it appears in peptide catalogues, and what changes because of it.
- NAD+ Molecular StructureTwo nucleotides, a pyrophosphate bridge, and a positive charge on the nicotinamide ring. Where the + in NAD+ comes from and what it does.